Lakeside Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Lakeside Advisors's MDT Position: Q3 2026 in Review
Lakeside Advisors reduced its Medtronic (MDT) stake by 5.7% in Q3 2026, selling an estimated $58.4K and leaving 10,905 shares worth $941K. The position accounts for 0.55% of the portfolio, ranked #31.
Lakeside Advisors first reported a position in MDT in Q2 2022 and has held it in 18 quarters since. The position peaked at $1.56M in Q2 2023. 1,676 funds tracked by Wall St. Rank hold MDT as of Q3 2026.
- Lakeside Advisors held 10,905 shares of Medtronic worth $941K as of Q3 2026.
- Lakeside Advisors sold 663 Medtronic shares in Q3 2026, an estimated $58.4K.
- Medtronic made up 0.55% of Lakeside Advisors's portfolio in Q3 2026, its #31 holding.
- Lakeside Advisors first reported a position in Medtronic in Q2 2022 and has held it in 18 quarters since.
- Lakeside Advisors's Medtronic position peaked at $1.56M in Q2 2023.
- 1,676 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.
Based on Lakeside Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.